rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0009566,
umls-concept:C0011847,
umls-concept:C0011854,
umls-concept:C0014507,
umls-concept:C0021641,
umls-concept:C0031117,
umls-concept:C0087111,
umls-concept:C0332152,
umls-concept:C1280500,
umls-concept:C1948041,
umls-concept:C2587213,
umls-concept:C2603343
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-4-29
|
pubmed:databankReference |
|
pubmed:abstractText |
To evaluate the impact of former intensive versus conventional insulin treatment on neuropathy in Diabetes Control and Complications Trial (DCCT) intensive and conventional treatment subjects with type 1 diabetes 13-14 years after DCCT closeout, during which time the two groups had achieved similar A1C levels.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-10023127,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-10333910,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-10666428,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-12020338,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-12882869,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-14570951,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-15673800,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-16371630,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-16443884,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-19064853,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-20956699,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-7031500,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-7555480,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-7887548,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-8366922,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150297-8526459
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1935-5548
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1090-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20150297-Diabetes Mellitus, Type 1,
pubmed-meshheading:20150297-Diabetic Neuropathies,
pubmed-meshheading:20150297-Follow-Up Studies,
pubmed-meshheading:20150297-Hemoglobin A, Glycosylated,
pubmed-meshheading:20150297-Hyperglycemia,
pubmed-meshheading:20150297-Hypoglycemic Agents,
pubmed-meshheading:20150297-Incidence,
pubmed-meshheading:20150297-Insulin,
pubmed-meshheading:20150297-Median Neuropathy,
pubmed-meshheading:20150297-Neural Conduction,
pubmed-meshheading:20150297-Outcome Assessment (Health Care),
pubmed-meshheading:20150297-Peroneal Neuropathies,
pubmed-meshheading:20150297-Prevalence,
pubmed-meshheading:20150297-Randomized Controlled Trials as Topic
|
pubmed:year |
2010
|
pubmed:articleTitle |
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
|
pubmed:affiliation |
Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA. jwalbers@umich.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|